ADENOSQUAMOUS CELL LUNG CANCER

ADENOSQUAMOUS CELL LUNG CANCER was reported 48 times

ADENOSQUAMOUS CELL LUNG CANCER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Provitamin D2 Compound [EPC] 1 0.0000
1 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1 0.0000
2 Cholinergic Muscarinic Antagonist [EPC] 1 0.0000
3 Phosphodiesterase 5 Inhibitor [EPC] 3 0.0000
4 Alkylating Drug [EPC] 5 0.0000
5 Programmed Death Receptor-1 Blocking Antibody [EPC] 2 0.0000
6 Ester Local Anesthetic [EPC] 1 0.0000
7 RANK Ligand Inhibitor [EPC] 4 0.0000
8 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
9 Nitroimidazole Antimicrobial [EPC] 1 0.0000
10 Endothelin Receptor Antagonist [EPC] 3 0.0000
11 Androgen Receptor Inhibitor [EPC] 1 0.0000
12 Thalidomide Analog [EPC] 7 0.0000
13 Non-Standardized Chemical Allergen [EPC] 1 0.0000
14 Azole Antifungal [EPC] 2 0.0000
15 Janus Kinase Inhibitor [EPC] 2 0.0000
16 Anti-IgE [EPC] 1 0.0000
17 Amide Local Anesthetic [EPC] 1 0.0000
18 Platinum-based Drug [EPC] 3 0.0000
19 Antiarrhythmic [EPC] 1 0.0000
20 Aminosalicylate [EPC] 1 0.0000
21 5-alpha Reductase Inhibitor [EPC] 1 0.0000
22 Interleukin-23 Antagonist [EPC] 1 0.0000
23 Antirheumatic Agent [EPC] 1 0.0000
24 Parathyroid Hormone Analog [EPC] 1 0.0000
25 Proton Pump Inhibitor [EPC] 5 0.0000
26 Sulfonylurea [EPC] 1 0.0000
27 Tumor Necrosis Factor Blocker [EPC] 8 0.0000
28 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
29 Kinase Inhibitor [EPC] 4 0.0000
30 Microtubule Inhibitor [EPC] 1 0.0000
31 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
32 Corticosteroid [EPC] 6 0.0000
33 Nonsteroidal Anti-inflammatory Drug [EPC] 5 0.0000
34 Opioid Agonist [EPC] 1 0.0000
35 Platelet Aggregation Inhibitor [EPC] 2 0.0000
36 Vitamin D [EPC] 1 0.0000
37 Vitamin B12 [EPC] 1 0.0000
38 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
39 Vitamin C [EPC] 1 0.0000
40 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
41 Insulin Analog [EPC] 1 0.0000
42 Benzodiazepine [EPC] 1 0.0000